CAD 0.37
(5.71%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 5.14 Million | 4.64 Million | 4.08 Million | 7.78 Million | - |
Cost of Revenue | 1.12 Million | 2.14 Million | 1.41 Million | 1.69 Million | - |
Gross Profit | 4.02 Million | 2.5 Million | 2.67 Million | 6.09 Million | - |
Operating Expenses | 7.47 Million | 7.08 Million | 5.73 Million | 100.13 Thousand | 37.52 Thousand |
Selling, General and Administrative Expenses | 3.93 Million | 4.97 Million | 3.59 Million | 100.13 Thousand | 37.52 Thousand |
Research and Development Expenses | 1.64 Million | 2.1 Million | 1.12 Million | 1.26 Million | - |
Other Expenses | -1.66 Million | -6500.00 | 1 Million | - | - |
Cost and Expenses | 6.76 Million | 9.22 Million | 7.15 Million | 100.13 Thousand | 37.52 Thousand |
Operating Income | -2.95 Million | -4.57 Million | -4.33 Million | -100.13 Thousand | -37.52 Thousand |
Interest Expense | 1.49 Million | 979.94 Thousand | 1.03 Million | - | - |
Income Tax Expense | 2.00 | 5613.59 | 2356.00 | -206.29 Thousand | -171.86 Thousand |
Earnings before Tax | -1.63 Million | -8.1 Million | -10.66 Million | -100.13 Thousand | -37.52 Thousand |
Net Income | -1.63 Million | -8.11 Million | -10.66 Million | -100.13 Thousand | -37.52 Thousand |
Earnings Per Share Basic | -0.08 | -0.44 | -1.30 | -0.01 | -0.01 |
Earnings Per Share Diluted | -0.08 | -0.44 | -1.30 | -0.01 | -0.01 |
Weighted Average Shares Outstanding | 21.14 Million | 18.45 Million | 8.22 Million | 8 Million | 4 Million |
Weighted Average Shares Outstanding (Diluted) | 21.14 Million | 18.45 Million | 8.22 Million | 8 Million | 4 Million |
Gross Margin | 0.78 | 0.54 | 0.65 | 0.78 | - |
EBIT Margin | 0.21 | -0.67 | -0.39 | -0.01 | - |
Profit Margin | -0.32 | -1.75 | -2.61 | -0.01 | - |
EBITDA | 1.08 Million | -4.25 Million | -10.15 Million | 944.55 Thousand | -37.52 Thousand |
Earnings Before Tax Margin | -0.57 | -0.99 | -1.06 | -0.01 | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 792.99 Thousand | 1.03 Million | 971.35 Thousand | 5.14 Million | 1.03 Million | 894.73 Thousand |
Cost of Revenue | 132.68 Thousand | 444.82 Thousand | 281.29 Thousand | 1.61 Million | 203.59 Thousand | 336.37 Thousand |
Gross Profit | 660.3 Thousand | 587.41 Thousand | 690.06 Thousand | 3.53 Million | 831.67 Thousand | 558.36 Thousand |
Operating Expenses | 1.41 Million | 2.15 Million | 2.24 Million | 8.33 Million | 992.5 Thousand | 1.16 Million |
Selling, General and Administrative Expenses | 965.86 Thousand | 1.43 Million | 1.8 Million | - | 550.26 Thousand | 770.56 Thousand |
Research and Development Expenses | 426.65 Thousand | 725.67 Thousand | 439.75 Thousand | - | 422.52 Thousand | 370.95 Thousand |
Other Expenses | 18.5 Thousand | - | - | - | - | 27.2 Thousand |
Cost and Expenses | 1.54 Million | 2.6 Million | 2.52 Million | 9.94 Million | 1.19 Million | 1.49 Million |
Operating Income | -750.71 Thousand | -1.56 Million | -1.55 Million | -4.79 Million | -160.83 Thousand | -603.42 Thousand |
Interest Expense | 117.91 Thousand | 151.53 Thousand | 784.38 Thousand | 1.49 Million | 162.66 Thousand | 296.27 Thousand |
Income Tax Expense | 130.02 Thousand | -4.00 | 784.38 Thousand | 2.00 | 102.13 Thousand | 296.27 Thousand |
Earnings before Tax | -352.43 Thousand | -2.27 Million | 1.14 Million | -1.63 Million | -323.49 Thousand | -1.44 Million |
Net Income | -352.43 Thousand | -2.27 Million | 1.14 Million | -1.63 Million | -323.49 Thousand | -1.44 Million |
Earnings Per Share Basic | -0.01 | -0.08 | 0.07 | - | -0.02 | -0.08 |
Earnings Per Share Diluted | -0.01 | -0.08 | 0.07 | - | -0.02 | -0.08 |
Weighted Average Shares Outstanding | 28.46 Million | 28.44 Million | 21.14 Million | 21.14 Million | 19.15 Million | 19.09 Million |
Weighted Average Shares Outstanding (Diluted) | 28.46 Million | 28.44 Million | 21.14 Million | 21.14 Million | 19.15 Million | 19.09 Million |
Gross Margin | 0.83 | 0.57 | 0.71 | 0.69 | 0.80 | 0.62 |
EBIT Margin | -0.92 | -1.25 | -0.91 | - | -0.14 | -0.65 |
Profit Margin | -0.44 | -2.20 | 1.18 | -0.32 | -0.31 | -1.61 |
EBITDA | -733.15 Thousand | -1.29 Million | -880.61 Thousand | - | -141.1 Thousand | -583.16 Thousand |
Earnings Before Tax Margin | -0.95 | -1.52 | -1.60 | -0.93 | -0.16 | -0.67 |
GR1T
TFCILTD
MMM
VPLM
JUBLPHARMA
300220